Start-Ups Swimming ...
Health Care: Drugs
Peregrine Pharmaceuticals Inc. (PPHM: NASDAQ)
$1.71 0.09 | 5.56%
05/24/13 - 11:10 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.62 |
| 52 Week High | 5.50 |
| 52 Week Low | 0.42 |
| Avg. Daily Vol. (Mil) | 2.60 |
| Beta (3 year) | 1.56 |
| Share Related Items | |
| Mkt Cap (Mil) | 222.12 |
| Shares Out (Mil) | 137.11 |
| Float (Mil) | 103.31 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.50 |
| Current Ratio | 1.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 11.39 |
| Price/Book | 12.77 |
| Price/Cash Flow | -57.50 |
| Per Share Data | |
| Earnings | -0.29 |
| Sales | 0.14 |
| Book Value | 0.13 |
| Cash Flow | -0.03 |
| Business Summary | |
|---|---|
| Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer. | |
| General Information | |
| 14282 Franklin Avenue
Suite 100 Tustin, CA 92780 |
|
| www.peregrineinc.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 172 | |
| CEO: Mr. Steven W. King | |
| Short Interest | |
| Current Month (Mil) | 11.56 |
| Previous Month (Mil) | 11.99 |
| Short Interest Ratio (Days) | 6.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -13.20 |
| Return on Investments | -28.00 |
| Profitability | |
| Gross Margin | 52.50 |
| EBIT Margin | n.a. |
| Profit Margin | -25.20 |
Portfolios with PPHM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserStocks
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest PPHM Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 04.04.13 | 01:04 pm
- Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug 02.13.13 | 09:02 am
- Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharma 01.18.13 | 08:01 am
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- The Worst Biotech CEO of 2012 Is... 12.07.12 | 09:12 am
- Peregrine Shows Desperation in Dusting Off Ancient Brain Tumor Drug 12.05.12 | 09:12 am
- Your Vote Counts: Who Is the Worst Biotech CEO of 2012? 12.04.12 | 08:12 am
- The Next Big Thing In Biotech: Worst CEO Candidates
11.23.12 | 05:11 am - Acadia Pharma Selling Stock Ahead of Key Study Results 11.06.12 | 12:11 pm
- Hemispherx ATM Withdrawals Raise A Red Flag 10.08.12 | 10:10 am
Press Releases for PPHM
- Faruqi & Faruqi, LLP Is Investigating Peregrine Pharmaceuticals Inc. On Behalf Of Its Shareholders - PPHM - PR Newswire 04.09.13 | 08:04 am
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Zillow, Inc. (Z) And SinoHub, Inc. (SIHI) And Investigation Of Peregrine Pharmaceuticals, Inc. (PPHM) - PR Newswire 12.19.12 | 12:12 pm
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of Freeport-McMoRan Copper & Gold Inc. (FCX), Peregrine Pharmaceuticals, Inc. (PPHM) And Kayak Software Corporation (KYAK) And Class Action Against Zillow, Inc. (Z) - PR Newswire 12.07.12 | 12:12 pm
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Align Technology, Inc. (ALGN) And Abiomed, Inc. (ABMD) And Investigation Of Peregrine Pharmaceuticals, Inc. (PPHM) - PR Newswire 12.05.12 | 01:12 pm
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of Young Innovations, Inc. (YDNT), Peregrine Pharmaceuticals, Inc. (PPHM) And Health Management Associates, Inc. (HMA) - PR Newswire 12.04.12 | 08:12 pm
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Peregrine Pharmaceuticals, Inc. (PPHM) And Investigation Of Merge Healthcare Incorporated (MRGE), Mandalay Digital Group Inc. (MNDL) And Sysco Corporation (SYY) - PR Newswire 11.26.12 | 02:11 pm
- Levi & Korsinsky, LLP Announces Investigation Of Kayak Software Corporation (KYAK) And JDA Software Group Inc. (JDAS) And Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) And Peregrine Pharmaceuticals, Inc. (PPHM) - PR Newswire 11.20.12 | 01:11 pm
- Bernstein Liebhard LLP Announces That Eight Days Remain To File A Motion For Lead Plaintiff In Class Action Concerning Peregrine Pharmaceuticals, Inc. - PR Newswire 11.19.12 | 02:11 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Peregrine Pharmaceuticals, Inc. To Contact The Firm - PR Newswire 11.17.12 | 09:11 am
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Peregrine Pharmaceuticals, Inc. (PPHM) And Gold Resource Corporation (GORO) And Investigation Of White River Capital, Inc. (RVR) - PR Newswire 11.16.12 | 02:11 pm
Partner Headlines for PPHM
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 09.26.12 | 09:09 am
- Company News for September 25, 2012 - Corporate Summary - NASDAQ 09.25.12 | 01:09 pm
- Company News for September 25, 2012 - Corporate Summary - Zacks 09.25.12 | 10:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- Pre-Market Earnings Report for September 10, 2012 : JW/A, TITN, PPHM - NASDAQ 09.07.12 | 08:09 pm
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 08.17.12 | 09:08 am
- Ultimate Market Recap: Siri Fans Losing Faith, SuperValu in "Neutral" Territory - Wall St. Cheat Sheet 07.16.12 | 09:07 am
- Madison Square Garden SETTLED Dispute and 4 Hot Stocks To Watch - Wall St. Cheat Sheet 07.16.12 | 02:07 am
